Aneuploidy is a condition where a cell has the wrong number of chromosomes. Instead of the usual 46 chromosomes that human cells carry (organized as 23 pairs), an aneuploid cell has one or more extra chromosomes, or is missing one or more. It’s the most common type of chromosomal abnormality, and it plays a role in everything from miscarriage to cancer to conditions like Down syndrome.
How Aneuploidy Happens
Human cells reproduce by dividing, and during division, chromosomes need to be copied and sorted into two new cells with exactly the right number. Aneuploidy occurs when this sorting process goes wrong, a failure called nondisjunction. Instead of each new cell getting one copy of a chromosome, one cell ends up with two copies and the other gets none.
At the molecular level, the most common cause involves a problem with how chromosomes physically attach to the machinery that pulls them apart. During cell division, protein structures called kinetochores connect each chromosome to a network of fibers (the spindle) that pulls the chromosomes to opposite ends of the cell. Sometimes a chromosome gets attached to fibers pulling in both directions at once, an arrangement called merotely. These misattachments happen naturally during the early stages of division, and the cell usually corrects them. When correction fails, a chromosome lags behind and ends up in the wrong cell. The error is irreversible once the cell finishes dividing.
Monosomy, Trisomy, and Other Types
Aneuploidy falls into a few categories depending on whether chromosomes are missing or extra:
- Monosomy: A cell has only one copy of a chromosome instead of the usual pair (45 total chromosomes). Most autosomal monosomies are fatal very early in development.
- Trisomy: A cell has three copies of a chromosome instead of two (47 total). This is far more common than monosomy in live births.
- Tetrasomy and beyond: Rarer situations where four or more copies of a chromosome are present, sometimes involving the sex chromosomes.
Most trisomies are not compatible with life. A pregnancy with trisomy of most chromosomes will end in miscarriage, often before the person even knows they’re pregnant. Only a handful of trisomies can result in a live birth.
Aneuploidies That Affect Autosomes
The autosomes are chromosomes 1 through 22, the non-sex chromosomes. Three autosomal trisomies are seen in live births:
Trisomy 21 (Down syndrome) is the most common viable autosomal trisomy and the leading genetic cause of intellectual disability. An extra copy of chromosome 21 produces a recognizable pattern of physical features along with involvement of multiple organ systems. Most individuals have mild to moderate intellectual and learning differences. There are increased risks of congenital heart defects, blood disorders, autoimmune conditions, sleep-disordered breathing, sensory problems like hearing and vision changes, and early-onset Alzheimer disease.
Trisomy 18 (Edwards syndrome) and trisomy 13 (Patau syndrome) are far more severe. Both involve major organ malformations and severe developmental differences. Most pregnancies with these trisomies end in miscarriage, and the majority of babies born with either condition do not survive beyond the first year.
Aneuploidies That Affect Sex Chromosomes
Sex chromosome aneuploidies tend to be milder than autosomal ones, partly because the body already has a natural mechanism for inactivating extra X chromosomes.
Turner syndrome results from the complete or partial loss of an X chromosome, giving a karyotype of 45,X in about half of cases. The other half involve mosaicism (some cells normal, some missing an X) or structural changes to the X chromosome. It affects only females and is characterized by short stature, possible heart defects, lymphatic swelling in infancy, and differences in learning and attention. Ovarian function is typically reduced, which affects puberty and fertility.
Klinefelter syndrome involves one or more extra X chromosomes in males, with about 80% of cases showing a 47,XXY karyotype. Features are highly variable but can include increased height, reduced testosterone production, small testes, infertility, breast tissue development, and differences in speech, language, and attention. Some individuals are diagnosed in childhood because of developmental delays, while others aren’t identified until adulthood during a fertility evaluation.
Other sex chromosome patterns like 47,XYY and 47,XXX also occur. These often produce subtler effects, and many individuals are never diagnosed.
Aneuploidy and Miscarriage
Roughly half of all first-trimester miscarriages are caused by fetal chromosomal abnormalities, and aneuploidy accounts for the vast majority of those. In a study of 832 miscarriage samples, 44% had abnormal chromosomes, and 84% of those abnormalities were aneuploidies, most commonly involving chromosomes 13, 16, 18, 21, 22, X, and Y.
This means that early pregnancy loss is, more often than not, the result of a random chromosomal sorting error rather than anything the parents did or didn’t do. The embryo simply received a combination of chromosomes that couldn’t support normal development.
How Maternal Age Affects Risk
The relationship between maternal age and aneuploidy risk is well established, though the pattern isn’t as simple as “older equals higher risk.” In a large analysis of over 12,000 karyotype reports, the highest odds of fetal aneuploidy were actually in mothers under 20, with an odds ratio of 6.65. Mothers over 40 had an odds ratio of 3.59, and those aged 35 to 39 had an odds ratio of 2.48, both compared to mothers in the middle age range.
The specific types of aneuploidy also shift with age. Trisomy 13 and trisomy 18 were significantly more frequent in mothers over 40. Sex chromosome aneuploidies were more common in the 35 to 39 age group. These patterns reflect the fact that eggs age along with the person carrying them, and the cellular machinery responsible for chromosome sorting becomes less reliable over time.
How Aneuploidy Is Detected
Prenatal screening has improved dramatically with the development of non-invasive prenatal testing, or NIPT. This blood test analyzes fragments of fetal DNA circulating in the pregnant person’s blood and can screen for the most common trisomies as early as 10 weeks.
NIPT’s accuracy is striking. For trisomy 21, detection rates consistently reach 99 to 100% in singleton pregnancies, with false positive rates as low as 0.05%. That’s a massive improvement over older screening methods like nuchal translucency ultrasound combined with blood markers, which had false positive rates around 5%. For trisomy 18, sensitivity runs between 90 and 97%, and for trisomy 13, between 91 and 100%. Specificity for all three conditions exceeds 99.9%.
A positive NIPT result is not a diagnosis, though. Confirmatory testing through amniocentesis or chorionic villus sampling, which directly analyzes fetal chromosomes, is still needed before any definitive conclusions are drawn. NIPT is a screening tool, and while its false positive rate is extremely low in percentage terms, the rarity of these conditions means a positive result still warrants confirmation.
Aneuploidy in Cancer
Aneuploidy isn’t just a prenatal concern. It’s also a hallmark of cancer. Cells from solid tumors almost invariably show abnormal chromosome numbers, and the ongoing chromosome sorting errors (called chromosomal instability) that produce aneuploidy are among the earliest recognized features of cancer cells.
In tumors, aneuploidy serves as fuel for evolution. Each time a cancer cell divides with the wrong number of chromosomes, it creates daughter cells with different genetic makeups. This diversity within a single tumor, known as intratumor heterogeneity, is what makes cancer so difficult to treat. Some of those variant cells may be resistant to a particular drug, allowing them to survive treatment and repopulate the tumor. Increased chromosomal instability has been linked to metastatic progression in prostate, pancreatic, breast, colorectal, and kidney cancers, and it has long been associated with multidrug resistance.
In this context, aneuploidy isn’t a single event that causes cancer. It’s an ongoing process that allows tumors to adapt, spread, and resist therapy by constantly reshuffling their genetic material.